Innovation Pharmaceuticals Inc (IPIX)

[SitTight]

Good to hear this from Dr DeGrado.

DeGrado continued: “I look forward to investigating Brilacidin further. Small molecule therapeutics with novel antiviral mechanisms of action will always be urgently needed. Given Brilacidin exerts antiviral activity prior to infection of cells, developing Brilacidin for potential prophylactic use by targeting the nasal passageway and lungs may be a particularly appealing clinical pathway.”

This to me means:
1) Dr DeGrado is still actively on board. Major point to have this star power in our corner.
2) Dr DeGrado is actively investigating Brilacidin further in his lab. I suppose this is paid by the university free of charge to us.
3) His insight into how to position Brilacidin in a Covid context is invaluable.

Besides that, I agree with FatAlbert that a strong partner would be ideal to finally unleash the power of Brilacidin commercially.